https://orcid.org/0000-0002-1010-276X
Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yuanze Du, Yi Wang, Ting Zhang, Juanjuan Li, Hewei Song, Yuanyuan Wang, Yifei Xu, Jingwen Cui, Ming Yang, Zengwu Wang, Xiuyun Wu & Chunping Wang. (2023) Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review. Expert Review of Vaccines 22:1, pages 193-206.
Read now
Read now
JP Sevilla, Daria Burnes, Rehab Zakaria El Saie, Hammam Haridy, Matt Wasserman, Sarah Pugh, Johnna Perdrizet & David Bloom. (2022) Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Jorge A. Gómez, Thatiana de Jesus Pereira Pinto, Javier Nieto Guevara & Tatiana Guimarães de Noronha. (2022) Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants”. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Articles from other publishers (6)
Michele Wilson, Cheryl McDade, Anna Trisia Beby-Heijtel, Angela Waterval-Overbeek, Vishalini Sundaram & Johnna Perdrizet. (2023) Assessing Public Health Impact of Four Pediatric Pneumococcal Conjugate Vaccination Strategies in the Netherlands. Infectious Diseases and Therapy 12:7, pages 1809-1821.
Crossref
Crossref
M. Sakil Syeed, Priyanka Ghule, Lan M. Le, Sajesh K. Veettil, Emily K. Horn, Johnna Perdrizet, Matt Wasserman, Ammarin Thakkinstian & Nathorn Chaiyakunapruk. (2023) Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies. Value in Health 26:4, pages 598-611.
Crossref
Crossref
Liping Huang, Cheryl L. McDade, Johnna E. Perdrizet, Michele R. Wilson, Sophie A. Warren, Susan Nzenze & Renilla Sewdas. (2023) Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease. Infectious Diseases and Therapy 12:3, pages 933-950.
Crossref
Crossref
Johnna Perdrizet, Emily Horn, Winniefer Nua, Judith Perez-Peralta, Jennifer Nailes, Jaime Santos & Anna Ong-Lim. (2022) Response to Gomez et al.’s Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”. Infectious Diseases and Therapy.
Crossref
Crossref
Johnna Perdrizet, Emily K. Horn, Winniefer Nua, Judith Perez-Peralta, Jennifer Nailes, Jaime Santos & Anna Ong-Lim. (2021) Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants. Infectious Diseases and Therapy 10:4, pages 2625-2642.
Crossref
Crossref
Michele R. Wilson, Cheryl L. McDade, Johnna E. Perdrizet, Annick Mignon, Raymond A. Farkouh & Matt D. Wasserman. (2021) Validation of a Novel Forecasting Method for Estimating the Impact of Switching Pneumococcal Conjugate Programs: Evidence from Belgium. Infectious Diseases and Therapy 10:3, pages 1765-1778.
Crossref
Crossref